Join Fox News for access to this content Plus special access to select articles and other premium content with your account - free of charge. Please enter a valid email address. By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy, which includes our Notice of
Lucid Diagnostics, a New York-based biotech company, is looking to revolutionize esophageal cancer prevention with a new test that only requires taking a single, vitamin-sized pill.
Lucid Diagnostics, a New York-based biotech company, is looking to revolutionize esophageal cancer prevention with a new test that only requires taking a single, vitamin-sized pill.
In the December issue of the Proceedings of the National Academy of Sciences, Wilmer Eye Institute researchers at Johns Hopkins Medicine have found how a molecular pathway involving oxidative stress, or an imbalance of molecular oxygen in cells, an